Mercia Fund announces investment in emerging UK tech start-ups
Fund has backed £250,000 in natural search specialist Intelligent Positioning and £50,000 in life sciences business CDL
Investor in UK technology start-ups, Mercia Fund Management (MFM), has announced a £250,000 capital injection in new portfolio company Intelligent Positioning, as well as an additional £50,000 investment into CYP Design Ltd (CDL).
Intelligent Positioning, a real-time natural search technology developer, helps clients optimise their web presence by controlling and improving their Search Engine Optimisation (SEO) and online strategy.
The company will use the finance to promote its core product, Pi Diametrics – a multilingual SEO platform – and cement its position as the market leader in natural search applications for intelligence, performance and optimisation.
Intelligent Positioning claims that 85% of its customers see a 40% increase in traffic within the first year of using its system, and has secured contracts with global brands including Marks & Spencer, Virgin Active, AXA and L’Oreal.
Life sciences firm CDL develops technology to make pre-clinical drug safety tests cheaper, more efficient and more convenient. With such trials costing up to £100m, an improvement of just 10% in predicting failures could save the industry an estimated £64m in development costs for every drug.
Daniel Titterton, co-founder and CEO of Intelligent Positioning, said: “In a very competitive space we have gone through the hard yards of proving Pi Datametrics’ worth with some of the world’s biggest and most demanding digital brands. With Mercia on board we now have the right partner to accelerate the business in value and capability, both now and in the future.”
David Gask, executive chairman of CDL, commented:
“The funding from MFM forms part of a further £275,000 contributed by other EIS investors, allowing CDL to take the technology forward into the next growth stage.We are grateful to MFM for their continued support, and we look forward especially to working with Dr. Nicola Broughton, who has extensive knowledge and expertise within the life sciences sector.”